[Efficacy and problems in combination therapy using lamivudine and interferon for chronic hepatitis B].
Saito
Takafumi
T
Division of Gastroenterology, Department of Internal Medicine and Molecular Therapeutics, Yamagata University School of Medicine.
Watanabe
Hisayoshi
H
Togashi
Hitoshi
H
Kawata
Sumio
S
D020816:Amino Acid Motifs / Q000235:genetics; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000494:pharmacology; D024882:Drug Resistance, Viral / Q000235:genetics; D004359:Drug Therapy, Combination; D006515:Hepatitis B virus / Q000187:drug effects / Q000201:enzymology / Q000235:genetics; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D006801:Humans; D007372:Interferons / Q000008:administration & dosage*; D019259:Lamivudine / Q000008:administration & dosage* / Q000494:pharmacology; D009154:Mutation; D012194:RNA-Directed DNA Polymerase / Q000737:chemistry
D000998:Antiviral Agents; D019259:Lamivudine; D007372:Interferons; D012194:RNA-Directed DNA Polymerase